|
Originally published In Press as doi:10.1074/jbc.M104005200 on June 20, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32330-32337, August 24, 2001
Synemin May Function to Directly Link Muscle Cell Intermediate
Filaments to Both Myofibrillar Z-lines and Costameres*
Robert M.
Bellin §,
Ted W.
Huiatt ,
David R.
Critchley¶, and
Richard M.
Robson
From the Muscle Biology Group, Departments of
Biochemistry, Biophysics, and Molecular Biology and of Animal Science,
Iowa State University, Ames, Iowa 50011-3260, and ¶ Department of
Biochemistry, University of Leicester, University Road, Leicester LE1
7RH, United Kingdom
Received for publication, May 3, 2001, and in revised form, June 19, 2001
 |
ABSTRACT |
Synemin is a large intermediate filament (IF)
protein that has been identified in all types of muscle cells in
association with desmin- and/or vimentin-containing IFs. Our previous
studies (Bellin, R. M., Sernett, S. W., Becker, B., Ip, W.,
Huiatt, T. W., and Robson, R. M. (1999) J. Biol.
Chem. 274, 29493-29499) demonstrated that synemin forms
heteropolymeric IFs with major IF proteins and contains a binding site
for the myofibrillar Z-line protein -actinin. By utilizing blot
overlay assays, we show herein that synemin also interacts with the
costameric protein vinculin. Furthermore, extensive assays utilizing
the Gal4 yeast two-hybrid system demonstrate interactions
of synemin with desmin and vimentin and additionally define more
precisely the protein subdomains involved in the synemin/ -actinin
and synemin/vinculin interactions. The C-terminal ~300-amino acid
region of synemin binds to the N-terminal head and central rod domains
of -actinin and the ~150-amino acid C-terminal tail of vinculin.
Overall, these interactions indicate that synemin may anchor IFs to
myofibrillar Z-lines via interactions with -actinin and to
costameres at the sarcolemma via interactions with vinculin and/or
-actinin. These linkages would enable the IFs to directly
link all cellular myofibrils and to anchor the peripheral layer of
myofibrils to the costameres.
 |
INTRODUCTION |
Intermediate filaments
(IFs),1 along with
microfilaments and microtubules, comprise the three cytoskeletal
filament classes found in animal cells (1-4). The IFs are composed of
cell type-specific proteins that are assembled in vivo into
very long ~10-nm-diameter filaments (4-9). The superfamily of IF
proteins currently contains ~60 members (10), and novel members
continue to be identified (10-12). Because of the diversity among
members of the protein superfamily, it is possible that IFs within
different cell types may be formed that have diverse functions (4).
Additionally, because the majority of IFs found in living cells are
heteropolymeric in nature (i.e. composed of more that one IF
protein member), even more diverse functionality of an individual IF is
possible (4).
The IFs have long been considered to play an important role as
mechanical integrators of cellular space (2, 13, 14). The actual
mechanism by which this cytoskeletal integration occurs within cells,
however, remains poorly understood. For IFs to connect cell components,
some form or type of attachment of IFs to other cytoskeletal components
is necessary. These attachments could be indirect, via a cross-linking
protein such as plectin that binds to several cytoskeletal proteins
(10, 15), or direct, by linking IF proteins themselves to protein
components within other cellular structures (12).
Synemin was initially described as an IF-associated protein because it
colocalized and copurified with the IF proteins desmin and vimentin
(16-18). However, we recently demonstrated that synemin is, in fact,
an IF protein because the sequence contains the ~310-amino acid rod
domain characteristic of IF proteins (12, 19). Furthermore, we
demonstrated that synemin (1,604 residues, 182,187 Da) is a novel
member of the IF protein superfamily in that it contains an unusually
large C-terminal tail domain (1,290 residues). Synemin has been
localized with desmin- and/or vimentin-containing IFs in all types of
developing chick (20) and adult avian and porcine muscle cells (21),
chick lens cells (22, 23), human SW13 adrenal cortex adenocarcinoma
cells (12), and, most recently, rat radial glial cells (24). Because to
date synemin has always been found in the presence of at least one
major IF protein, and because it fails to form IFs by itself in
vitro (21) and when transfected into cells that lack other IF
proteins (12), we believe it is very likely that synemin only functions
within cells as a component of heteropolymeric IFs.
We have shown previously by blot overlay assays that synemin interacts
with both desmin and -actinin (12). We now show, by blot overlay
assays, a direct interaction between synemin and the tail domain of
vinculin. Furthermore, we demonstrate these interactions with
-actinin and vinculin and further define the specific binding sites
for these interactions by using the Gal4 yeast two-hybrid
system. These specific interactions further support a role for synemin,
as a component of heteropolymeric IFs, in directly attaching these IFs
to other cytoskeletal structures via direct protein/protein
interactions involving synemin.
Our major interest is to define how the cytoskeletal elements are
organized and attached to each other within muscle cells. We present a
schematic showing how synemin in striated muscle cells may serve as a
cytoskeletal cross-linking component by enabling synemin-containing
heteropolymeric IFs to (a) directly bind to myofibrillar
Z-lines and thereby link all cellular myofibrils via
synemin/ -actinin interactions and (b) help in
anchoring the peripheral layer of cellular myofibrils to the costameric
sites at the sarcolemma via synemin/vinculin and/or synemin/ -actinin interactions.
 |
EXPERIMENTAL PROCEDURES |
Protein Purification--
Synemin (12, 21) and vinculin (25)
were purified from avian smooth muscle as described previously.
Proteolytic fragments of vinculin were prepared by treatment with V8
protease (26). The precise cleavage site(s) in vinculin was determined
by protein microsequencing from polyvinylidene difluoride membrane in
the Iowa State University Protein Facility. The specific rod and tail domains of synemin were expressed in bacteria and purified (12).
Blot Overlay Assays--
Blots of samples of purified synemin,
desmin, vinculin, and proteolytically digested vinculin, plus a sample
of avian smooth muscle homogenate, were probed, by using blot overlay
procedures (12), with synemin, expressed synemin rod, and expressed
synemin tail domains. Binding was detected by use of polyclonal
antibody 2856, which has been characterized previously and shown to
recognize intact synemin, and both the rod and tail domains of synemin
(12).
Preparation and Transformation of Yeast Two-hybrid
Constructs--
Constructs used for desmin (27) and vimentin (28) have
been described. Constructs encoding the entire synemin molecule, as
well as specific domains of synemin, -actinin, and vinculin, were
generated by polymerase chain reaction and cloned into both the pPC86
and pPC97 yeast two-hybrid vectors originally described by Chevray and
Nathans (29). The pPC86 and pPC97 vector pair have been used in other
two-hybrid studies on IF proteins (27, 28, 30). The PCY2 strain of
yeast (29) was cotransformed with the Alkali-Cation Yeast
Transformation kit (Bio101) by using the manufacturer's protocol. An
empirically determined optimal amount of 400 ng of plasmid DNA was used
for each construct.
Fluorescence-based Semiquantitative Two-hybrid Assays--
A
fluorescence-based detection method was developed similar to that
recently described by Meng and Ip (31). Quantitative determinations of
all two-hybrid interactions were done by using the FluorAce
-galactosidase Reporter Assay Kit (Bio-Rad) modified for use with
yeast cells as follows. Yeast cultures were started with 2 ml of double
drop-out Leu Trp media and incubated in a
rotary incubator at 180 rpm, 30 °C for 72 h, followed by 3 h of protein induction in galactose-containing Leu
Trp media at 180 rpm, 30 °C. Yeast lysates were
prepared by freezing the yeast pellet in liquid nitrogen for 5 min and
resuspending it in 100 µl of Lysate Buffer (1 mM
MgCl2, 0.1% NaN3, and 10 mM sodium
phosphate, pH 7.0). An empirically determined amount of yeast
lysate (20 µl) was mixed with 50 µl of the kit's 1×
Reaction Buffer, which included -methylumbelliferyl
-D-galactopyranoside and -mercaptoethanol,
directly in the wells of a black microtiter plate kept on ice. The
plate was incubated for 3 h at 37 °C, followed by the
addition of 150 µl of the kit's 1× Stop Buffer. The plate was then
read with a Titertek Fluoroskan fluorescent microplate reader with
excitation at 355 nm and emission at 460 nm. The specificity of
interactions was confirmed by performing vector-swap experiments for
each protein pair. Both the original vector pair and the vector-swap pair were independently tested twice, with the numbers for each determination resulting from reaction wells set up in triplicate and
averaged. The quantitative data reported in the figures were calculated
by using an A600 measurement of each individual
culture to normalize the respective fluorescence reading. The resulting data were then used to calculate relative interaction affinities by
comparing each reading with the value determined for the synemin rod/desmin interaction that was included with each set of assays.
 |
RESULTS |
Blot Overlay Assays--
Analyses utilizing purified synemin and
vinculin, as well as bacterially expressed rod and tail domains of
synemin, and the proteolytic products of purified vinculin
resulting from V8 protease treatment were conducted to identify
interactions of specific protein domains. Vinculin was selected as a
potential interaction partner for synemin because it is a key
cytoskeletal protein potentially involved in signal transduction
pathways (32, 33) and because it is a component of the costameres (34),
one of the attachment sites for striated muscle cell IFs (35). V8
protease digestion of vinculin resulted in the production of variable
amounts of two low molecular mass bands (~24 kDa and ~22 kDa
in Fig. 1). Protein microsequencing of
these fragments revealed newly generated N termini having the sequences
LAPPKPPLPE and GEVPPPRPPP. These sequences agree precisely with residue
numbers 858-867 and 868-877, respectively, in the avian vinculin
sequence (GenBankTM accession number Y00312), therefore
showing that they both are tail fragments of vinculin. As shown in the
Control buffer overlay blots lacking any probe protein in
the overlay solution (Fig. 1, A and D), the
synemin polyclonal antibody 2856 labeled synemin present in the gizzard
homogenate (Fig. 1, A and D, lanes 1), purified synemin (Fig. 1A, lane 2), and
expressed synemin rod domain (Fig. 1D, lane 2)
but did not label purified vinculin (Fig. 1, A and
D, lanes 3), the small amount of intact purified vinculin remaining after V8 protease treatment (Fig. 1, A
and D, lanes 4), or any other proteins in the
gizzard homogenate (Fig. 1, A and D, lanes
1). As is shown in Fig. 1B, probing blots of vinculin
and V8-digested vinculin with purified intact synemin in the overlay
revealed an interaction of synemin with purified intact vinculin
(lane 3), the very small amount of intact vinculin remaining
in the V8 protease digest of vinculin (lane 4), and the
small tail domain fragment(s) of vinculin produced by the V8 protease
digestion (lane 4), but not with the large head domain fragment of vinculin that migrated with an approximate size
corresponding to 90 kDa. Additionally, an interaction between the probe
synemin in the overlay solution and desmin in the gizzard homogenate
lane (Fig. 1B, lane 1) can be seen, as we reported
previously (12). Probing blots (Fig. 1) with expressed synemin tail
(Fig. 1C) and rod domains (Fig. 1E) resulted in
binding patterns similar to that seen when using intact synemin,
although only weak binding to the vinculin tail domain is seen (Fig. 1,
C and E, lanes 4). It is evident that
synemin binds specifically to the vinculin tail domain because neither
synemin (Fig. 1B) nor synemin domains (Fig. 1, C
and E) bound to any of the other proteins (e.g.
filamin, myosin heavy chains, and actin) present in the gizzard
homogenate (Fig. 1B, C, and E,
lanes 1). The lack of binding to -actinin in the
gizzard homogenate (Fig. 1, B, C, and
E, lanes 1) was also evident in the
original blot overlay experiments depicting the synemin/ -actinin
interaction (12). In those studies, it appeared that the relatively
large amount of desmin in the gizzard homogenate, in comparison to the
amount of -actinin, seemed to "bind up" the available synemin
overlay protein, thereby obscuring the identification of the
interaction between synemin and -actinin. The synemin/ -actinin interaction was evident, however, with heavier loads of -actinin (12).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Blot overlay analysis of the interactions of
synemin and of specific synemin domains with vinculin. A-C
depict blots resulting from transfer of SDS-polyacrylamide gel
electrophoresis gels (lane 1, whole gizzard homogenate;
lane 2, purified synemin; lane 3, purified
vinculin; lane 4, V8 protease-digested vinculin) that were
overlaid with buffer only (A), purified intact synemin
(B), and bacterially expressed synemin tail domain
(C) before washing and detection with synemin polyclonal
antibody. D and E depict blots resulting from
transfer of SDS-polyacrylamide gel electrophoresis gels (lane
1, whole gizzard homogenate; lane 2, expressed synemin
rod domain; lane 3, purified vinculin; lane 4, V8
protease-digested vinculin) that were overlaid with buffer only
(D) and synemin rod domain (E) before washing and
detection with synemin polyclonal antibody. H and
T denote the approximate migration positions of the V8
protease-produced vinculin head and tail domains, respectively.
|
|
Two-hybrid Analysis--
Identification and analysis of
interactions by the Gal4 two-hybrid system included
sufficient controls to demonstrate that seemingly positive interactions
are not due to false positives of the assay system. This is especially
of concern when testing helical proteins, such as an IF protein rod
domain, because a charged helix attached to the DNA-binding portion of
Gal4 (as is present in the pPC97 vector) has been shown, in
some cases, to activate -galactosidase reporter gene expression
(36). The constructs used herein are shown in Fig.
2. As demonstrated in Fig.
3, when each of the constructs encoding a
domain of synemin (see Fig. 2) is cotransfected with a negative control
consisting of an empty two-hybrid vector (e.g. synemin rod
insert in pPC86, but no insert in pPC97), the resulting values from the
fluorescence assays were quite low, which indicates that none of the
synemin constructs significantly activates transcription by itself.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Constructs used in two-hybrid studies.
SN, avian synemin (GenBankTM accession number
U28143); Desmin, murine desmin (GenBankTM
accession number L22550); Vimentin, murine vimentin
(GenBankTM accession number M24849);
-Actinin/ -Act, avian -actinin
(GenBankTM accession number J03486); Vinc, avian
vinculin (GenBankTM accession number Y00312).
Numbers at the right of each construct refer to
the amino acid residues in the construct, with the N terminus of the
intact protein corresponding to residue number 1.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Negative controls for two-hybrid assays of
synemin constructs. The labels at the X axis
refer to the construct names defined in the Fig. 2 legend.
Vector refers to a two-hybrid vector without a cDNA
insert, which is included as a negative control. All fluorescence
values were calculated relative to the value (defined as 100) obtained
in the interaction of synemin rod domain with desmin (column
9) as described under "Experimental Procedures." Results from
vector-swap tests (i.e. columns 1-9) of each
interaction are shown as a pair of open and solid
bars, with error bars representing the standard error
of the mean. Open bars represent assays in which the synemin
insert is in the pPC97 vector, and a control vector (columns
1-8) or desmin (column 9) is in the pPC86 vector.
Solid bars represent assays in which the synemin insert is
in the pPC86 vector, and a control vector (columns 1-8) or
desmin (column 9) is in the pPC97 vector. Note that none of
the synemin constructs tested with a control (empty) vector yielded
significant amounts of transcription of the -galactoside
reporter.
|
|
Results from two-hybrid assays testing synemin/desmin interactions are
shown in Fig. 4. The rod domain of
synemin interacts strongly with desmin (Fig. 4, column 1),
as compared with the vector control (Fig. 4, column 9). The
strong interaction between synemin and desmin was expected because
other studies have shown that the rod domains of IFs are the primary
interaction domains between IF protein pairs (reviewed in Ref. 4).
Results shown in Fig. 4 (columns 2-8) demonstrate
that none of the tail domain constructs of synemin exhibit interactions
with desmin in these assays.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Two-hybrid assays of interactions involving
synemin and desmin. The gray bar represents a test of
desmin dimerization, hence no vector-swap test is possible. All
fluorescence values were calculated relative to the value (defined as
100) obtained in the interaction of synemin rod domain with desmin as
described under "Experimental Procedures." Note that only the rod
domain of synemin interacts significantly with desmin. For details on
graph format and labeling, see the Fig. 3 legend.
|
|
The results of the two-hybrid assays of the interactions between
synemin and vimentin (Fig. 5) were very
similar to those observed between synemin and desmin (Fig. 4), as may
be expected because of the high sequence homology between the type III
IF proteins vimentin and desmin (37), which are the major IF proteins of developing and mature striated muscle cells, respectively (12, 16,
20). The rod domain of synemin reacts most strongly with vimentin (Fig.
5, column 1), when compared with the vector control (Fig. 5,
column 9). The results shown in Fig. 5 (columns
2-8) demonstrate that none of the tail domain
constructs of synemin interact with vimentin, akin to the lack of
synemin tail interactions with desmin (Fig. 4).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Two-hybrid assays of interactions involving
synemin and vimentin. The gray bars represent tests of
protein dimerization, hence no vector-swap tests are possible. All
fluorescence values were calculated relative to the value (defined as
100) obtained for the interaction of synemin rod domain with desmin as
described under "Experimental Procedures." Note that only the rod
domain of synemin interacts with vimentin. For details on graph format
and labeling, see the Fig. 3 legend.
|
|
Results from two-hybrid analysis of interactions between synemin and
-actinin are shown in Fig. 6. Analysis
of these interactions must take into account that the full-length
-actinin pPC97 construct activated transcription by itself to a
moderate degree (Fig. 6, column 9). When compared with the
vector controls (Fig. 6, column 9), the interaction of
synemin with -actinin is specific for the tail domain of synemin
(Fig. 6, column 2). Analysis of the constructs of the
synemin tail domain split into four nonoverlapping parts indicates that
SN tail IIb has the strongest interaction (Fig. 6, column
8), thus mapping the interaction domain to the last quarter of the
C-terminal tail of synemin. Additionally, testing this tail domain
construct with domains of -actinin demonstrates interaction of the
SN tail IIb with both the N-terminal head domain of -actinin (Fig.
6, column 10), which contains the actin-binding site, and
the rod domain of -actinin (Fig. 6, column 12), which contains four spectrin-like repeats (38, 39). Each of these interactions is much stronger than the respective vector control results (cf. columns 10 and 11 and
columns 12 and 13 of Fig. 6). Two-hybrid assays
of the remaining synemin constructs with the three -actinin
constructs revealed no other strong
interactions.2

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Two-hybrid assays of interactions involving
synemin and -actinin. All fluorescence
values were calculated relative to the value (defined as 100) obtained
for the interaction of synemin rod domain with desmin as described
under "Experimental Procedures." Analysis of interactions with the
full-length -actinin construct (columns 1-8) requires
careful comparison with the "negative" control in column
9 ( ) because the pPC97 -actinin construct activates
transcription of the reporter to a moderate level (~20%) by itself.
This did not occur with the pPC86 -actinin construct ( ,
column 9). Note the positive interactions between
-actinin and synemin tail (column 2), synemin tail II
(column 4), and synemin tail IIb (column 8).
Furthermore, synemin tail IIb interacts with both the -actinin head
(column 10) and rod (column 12) domains. For
details on graph format and labeling, see the Fig. 3 legend.
|
|
The results of the two-hybrid assays of the interaction between synemin
and vinculin are shown in Fig. 7. Because
the head and tail domains within a single vinculin molecule are known
to interact in a fashion that blocks some protein interaction sites in
solution (26, 40), interactions with vinculin were tested on subdomains
of vinculin, rather than on the whole molecule. In agreement with the
blot overlay assays shown earlier (Fig. 1), the synemin rod (Fig. 7,
column 7) and synemin tail domains (Fig. 7, columns
8, 10, and 12) interact strongly with the
vinculin tail domain in comparison with the vector control (Fig. 7,
column 13). Within subdomains of the synemin tail domain,
the strongest interaction with the vinculin tail was found with the SN
tail IIb construct (Fig. 7, column 12). Thus, the end of the
tail domain and the rod domain (Fig. 7, column 7) of synemin
show affinity for the vinculin tail domain. Two-hybrid assays of the
remaining tail domain constructs of synemin with the vinculin
constructs revealed no other strong interactions.2

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Two-hybrid assays of interactions involving
synemin and vinculin. All fluorescence values were calculated
relative to the value (defined as 100) obtained for the interaction of
synemin rod domain with desmin as described under "Experimental
Procedures." Note that interactions are positive for both the rod
(column 7) and tail domains (columns 8, 10, and
12) of synemin with the small vinculin tail domain. For
details on graph format and labeling, see the Fig. 3 legend.
|
|
 |
DISCUSSION |
Identification of the interaction between synemin and vinculin is
an important advance in understanding linkages within the cytoskeleton.
Although it has long been recognized that IFs attach or insert into and
are thus somehow linked to protein-rich cytoskeletal/membrane attachment sites, the only well established mechanism for cytoskeletal attachment of IFs involves members of the plakin family (30, 41-43). Vinculin is a component of both cell-cell and cell-matrix type
adhesion plaques (44). The cell-matrix adhesion plaques include the
membrane-associated dense bodies in smooth muscle, the neuromuscular
and myotendenious junctions in skeletal muscle, and the costameres of
striated muscle cells (34, 45). The costameres, which are located
proximal to the sarcolemma at sites adjacent to the myofibrillar
Z-lines of the peripheral layer of myofibrils are, in fact, often
defined by the presence of vinculin (46-48). Thus, the interaction
between synemin and vinculin may serve as a mechanism for IF attachment
to the costameric regions. Vinculin, in turn, can be anchored to the
cell membrane via an interaction with the integrin-binding proteins
talin and -actinin (44, 49-51), which are also present in
costameres (52, 53). As a result, the synemin/vinculin/talin and/or
synemin/vinculin/ -actinin interaction(s) may also serve to link IFs
to the cell membrane.
The results of the Gal4 yeast two-hybrid assays provide
direct confirmation of the interactions involving synemin that were originally identified by blot overlay methods (Ref. 12 and the studies
herein). Although blot overlay methods have the advantage of utilizing
proteins prepared from their normal tissue source (i.e.
synemin, desmin, -actinin, and vinculin purified from muscle tissue), the Gal4 yeast two-hybrid assay has the advantage
of testing protein interactions within the context of a living cell. Thus, the combination of approaches and results reported herein and
previously (12) provide complementary evidence, obtained by at least
two different methods, of the interactions of synemin with desmin,
-actinin, and vinculin.
Although the usual and most basic application of the yeast two-hybrid
system is to determine whether two proteins have affinity for each
other (54), use of the yeast two-hybrid system in conjunction with a
quantitative detection method, as was used herein, also provides a
relative measurement of the strength of the protein-protein interaction
(31). The interactions between IF proteins were the strongest of those
we tested. To provide a useful "ruler" of relative protein
interaction strength, all values reported in this article are relative
to the value of the interaction measured between the synemin rod domain
and desmin. That interaction was very similar in strength to that
obtained for both the interaction between the synemin rod and vimentin
and the self-dimerization of the synemin rod. Although it might be
expected that all IF protein interactions would be of similar strength
because of the relatively high sequence homology and conservation in
overall length of the cytoplasmic IF rod domains, the strengths of the self-dimerization interactions of desmin and of vimentin were significantly greater than all of those that included the synemin rod
domain. It is notable that, based on the strength of the interactions shown herein, synemin is as likely to interact with desmin or vimentin
as it is with itself. Based upon studies of the copolymerization of the
large IF protein nestin with vimentin (55), it was suggested that the
mode of integration of the "large" IF proteins into mature IFs
initially involves formation of a heterodimer rather than a simple
homodimer of the large IF protein (i.e. synemin/desmin, rather than synemin/synemin). It recently has been suggested (4) that
large IF protein-containing heterodimers, together with homodimers of
the small IF proteins (e.g. desmin/desmin), then assemble
into filaments that contain a higher molar ratio of the small IF
protein subunits than of large IF protein subunits. The observation
that the total amount of synemin is only ~1% of the total amount of desmin in an adult muscle cell (16, 21, 56) is consistent with the
model proposed for assembly of heteropolymeric IFs (4).
In comparison to the strength of the IF protein/IF protein interactions
measured, the interactions between synemin and either -actinin or
vinculin are considerably weaker. Considering the nature of these
protein interactions, however, this finding is not unexpected. The IF
proteins have been shown repeatedly to interact with each other by
strong coiled-coil interactions between their ~310-amino acid-long
rod domains (5, 7, 8). The major force driving this protein interaction
is thought to be due to interactions of a hydrophobic stripe of apolar
residues along each of the -helical rod domains of two polypeptides
(6, 57) as well as to charge-charge interactions that further stabilize the rod domain interactions (58, 59). By comparison, the interactions of synemin with -actinin and with vinculin are unlikely to result from coiled-coil interactions because the tail domain of synemin lacks
any strongly helical domains needed for a coiled-coil interaction (12).
Results of the two-hybrid studies define more precisely the protein
domains involved in the interactions we reported recently between
synemin and -actinin (12). The -actinin molecule is composed of
an N-terminal head domain containing an actin-binding site, a central
rod domain composed of four spectrin-link repeats, and a C-terminal
tail domain containing two EF hand homology regions (38, 39, 60).
Assays utilizing several constructs of domains of both the synemin tail
and -actinin revealed the smallest interacting domains between the
two proteins to reside within the C-terminal ~300 amino acid residues
of the synemin tail and within both the head and rod domains of
-actinin (Fig. 6). The binding site for -actinin identified
within synemin seems logical because the end of the synemin tail may be
the domain extended farthest from the surface of the 10-nm core of the
IF and would therefore be more likely to reach -actinin molecules at
the myofibrillar Z-line.
The blot overlay results demonstrate an interaction between synemin and
vinculin. The two-hybrid assays provide further important information
regarding the specific protein domains involved in the synemin/vinculin
interaction. Use of the three separate constructs, two of which each
code for approximately half of the large vinculin head domain and one
that codes for the small C-terminal vinculin tail domain, reveals that
only the tail domain of vinculin has affinity for synemin (Fig. 7).
This small ~150-amino acid domain is a very interesting part of the
vinculin molecule (61). The tail domain of vinculin contains two
actin-binding sites, and their affinity for actin is regulated by
binding of the tail domain to a site on the large head domain of
vinculin, an interaction that, in turn, has been proposed by some
investigators to be controlled by the binding of specific phospholipids
(32, 33, 40, 62). Additionally, it was recently reported that the
vinculin tail domain may act as a dimerization domain for vinculin,
with actin filaments inducing the dimerization by stablizing
interactions between the tail domains of two vinculin molecules (63).
Whether some of these dynamic activities of the vinculin tail also
affect the binding to synemin is unknown. Whether vinculin head-tail association also regulates synemin binding was not directly addressed in the blot overlay assays shown (see Fig. 1) because full-length vinculin exists in an "open" conformation when blotted to a
membrane (64). In preliminary in vitro studies, however, we
have found that purified full-length vinculin does not bind when it is
overlaid onto synemin (i.e. the vinculin would be in the
closed conformation), in contrast to the positive interaction obtained
when bacterially expressed vinculin tail is overlaid onto
synemin.3 It is intriguing
that the tail domain of vinculin has affinity for both the rod domain
and the C-terminal ~300 amino acids of the very long tail domain of
synemin. Perhaps these two discrete vinculin-binding sites within
synemin bind to separate vinculin molecules in the costamere, which
would foster formation of a matrix/network between the IFs and vinculin
and thereby result in strong anchoring of the IFs to these sites.
The binding sites for synemin on both -actinin and vinculin exist
within protein domains that also contain actin-binding sites. Whereas
these findings may indicate that -actinin and vinculin act as
"tight linkers" between synemin-containing heteropolymeric IFs and
actin filaments, it is also possible that these IFs compete with actin
filaments for binding to these proteins. The latter option raises the
possibility that signal transduction pathways that affect actin
filament dynamics could also alter binding to synemin-containing IFs.
Conversely, it is possible that dynamic changes in the IF proteins,
such as those induced by covalent modifications including
phosphorylation (65) and ADP ribosylation (66), may also impact the
actin cytoskeleton. Synemin itself has been found to be an excellent
substrate for both phosphorylation (17) and ADP ribosylation (12) reactions.
Although the interactions identified for synemin with -actinin and
vinculin demonstrate a possible mechanism(s) of direct linkage between
IFs and other cytoskeletal structures, some recent studies have
implicated the protein plectin as an indirect mechanism for anchoring
muscle cell IFs to other cytoskeletal structures (67-69). Plectin is a
member of the plakin family of proteins that also includes the protein
desmoplakin, which is involved in anchoring IFs to desmosomes (30,
41-43). Plectin contains binding sites for protein components of all
three of the cytoskeletal filament classes (microtubules,
microfilaments, and IFs) (15, 70) and is often called a universal
cytoskeletal cross-linking protein (15, 71). It was recently shown that
plectin interacts with desmin (72). Thus, it appears likely that
plectin helps link IFs to other structures in muscle cells. Because
plectin has been shown to be a general cross-linking protein, synemin
may play the essential role in establishing the direct linkages between heteropolymeric IFs and the myofibrillar Z-line and costameric regions.
Once specific direct linkages are established, plectin may provide
additional structural support at these sites.
Recent studies indicate that synemin is a component of heteropolymeric
IFs within striated muscle cells (12, 21). These IFs are located at the
periphery of myofibrillar Z-lines, link adjacent myofibrils at their
Z-line levels, and extend from the Z-lines of the peripheral layer of
cellular myofibrils to the costameres along the inside of the
sarcolemma (35, 67, 68, 73-75). Based upon this localization and the
interactions of synemin (see Fig.
8A) with (a) the
major IF proteins vimentin and desmin, (b) the integral
myofibrillar Z-line and costameric protein -actinin, and
(c) the costameric protein vinculin, a likely cytoskeletal cross-linking role for synemin in striated muscle cells can be proposed
(see Fig. 8B for a schematic representation). The
synemin/desmin-containing heteropolymeric IFs closely encircle each
myofibrillar Z-line and are firmly anchored to the Z-lines by
interactions between the end of the synemin tail domain and domains
within -actinin. Likewise, the IFs extending from the Z-lines of the
peripheral layer of myofibrils to the costameric regions at the
sarcolemma are anchored there by interactions between synemin and
vinculin and/or -actinin. Because of the strong linkages of vinculin
and -actinin to the muscle cell membrane, the direct
synemin/vinculin and/or synemin/ -actinin interactions would
effectively connect the peripheral layer of myofibrils to the cell
membrane. The importance of these linkages has been shown in the muscle
cells of desmin knockout mice, which still contain synemin (76) but
lack IFs because synemin by itself is unable to form filaments without the presence of a major IF protein (12, 77). Structural observations of
striated muscle from desmin knockout mice reveal strain-induced muscle
cell damage including a major loss of Z-line alignment (78-83).
Because synemin appears to play an important cytoskeletal cross-linking
role as a component of heteropolymeric IFs in muscle cells, the
observed perturbations are what would be expected from observation of
muscle cells lacking either desmin or synemin. Overall, the
synemin-based linkages in striated muscle cells may enable the
heteropolymeric IFs to maintain myofibrillar Z-line alignment and
attachment and also to reduce stress on myofibrils during muscle
contraction by acting as a conduit to transmit some of the mechanical
strain from the myofibrils to the muscle cell membrane.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 8.
Summary of synemin protein interactions and a
schematic showing a proposed role for synemin in striated muscle
cells. A, the protein interactions involving the
synemin molecule as determined by the yeast two-hybrid system are
depicted. Numbers refer to the amino acid residues of
the avian synemin transcript (see Fig. 2). B, the diagram
shows the known location of heteropolymeric IFs at the Z-lines of
striated muscle cells. Also depicted are attachment points of IFs to
structures containing proteins that we have found to interact with
synemin. Our hypothesis is that heteropolymeric IFs are firmly anchored
to (a) the myofibrillar Z-lines by interactions between
synemin and -actinin, an integral Z-line protein (this interaction
would enable heteropolymeric IFs to link all adjacent myofibrils
together at their Z-lines), and (b) the costameres by
interactions of synemin with vinculin and/or -actinin (this
interaction would enable heteropolymeric IFs to firmly anchor the
peripheral layer of myofibrils to the costameres at the cell membrane).
The schematic in B was adapted from Ref. 13.
|
|
 |
ACKNOWLEDGEMENTS |
We thank Suzanne W. Sernett (Iowa State
University) for assistance with protein purification and blot overlay
experiments and Dr. Wallace Ip (University of Cincinnati Medical
Center) for the desmin and vimentin two-hybrid constructs and for
providing initial guidance with the two-hybrid system.
 |
FOOTNOTES |
*
This research was supported in part by grants from the
United States Department of Agriculture, NRICGP Award 99-35206-8676, and American Heart Association, Heartland Affiliate. This is Journal Paper J-19312 of the Iowa Agriculture and Home Economics Experiment Station, Ames, IA 50011, Projects 3597, 3900, and 2127, and supported by Hatch Act and State of Iowa funds.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Children's Hospital, Harvard Medical School, 300 Longwood Ave., Enders-961, Boston, MA 02115.
To whom correspondence should be addressed: Muscle Biology
Group, 3110 Molecular Biology Bldg., Iowa State University, Ames, IA
50011-3260. Tel.: 515-294-5036; Fax: 515-294-0453; E-mail: rmrobson@iastate.edu.
Published, JBC Papers in Press, June 20, 2001, DOI 10.1074/jbc.M104005200
2
R. M. Bellin and R. M. Robson, unpublished observations.
3
S. W. Sernett, R. M. Bellin, and R. M.
Robson, unpublished observations.
 |
ABBREVIATIONS |
The abbreviation used is:
IF, intermediate
filament.
 |
REFERENCES |
| 1.
|
Robson, R. M.
(1989)
Curr. Opin. Cell Biol.
1,
36-43
|
| 2.
|
Fuchs, E.,
and Weber, K.
(1994)
Annu. Rev. Biochem.
63,
345-382
|
| 3.
|
Fuchs, E.,
and Yang, Y.
(1999)
Cell
98,
547-550
|
| 4.
|
Herrmann, H.,
and Aebi, U.
(2000)
Curr. Opin. Cell Biol.
12,
79-90
|
| 5.
|
Herrmann, H.,
Haner, M.,
Brettel, M.,
Muller, S. A.,
Goldie, K. N.,
Fedtke, B.,
Lustig, A.,
Franke, W. W.,
and Aebi, U.
(1996)
J. Mol. Biol.
264,
933-953
|
| 6.
|
Herrmann, H.,
and Aebi, U.
(1998)
Curr. Opin. Struct. Biol.
8,
177-185
|
| 7.
|
Herrmann, H.,
and Aebi, U.
(1998)
Subcell. Biochem.
31,
319-362
|
| 8.
|
Herrmann, H.,
Haner, M.,
Brettel, M.,
Ku, N. O.,
and Aebi, U.
(1999)
J. Mol. Biol.
286,
1403-1420
|
| 9.
|
Strelkov, S. V.,
Herrmann, H.,
Geisler, N.,
Lustig, A.,
Ivaninskii, S.,
Zimbelmann, R.,
Burkhard, P.,
and Aebi, U.
(2001)
J. Mol. Biol.
306,
773-781
|
| 10.
|
Fuchs, E.,
and Cleveland, D. W.
(1998)
Science
279,
514-519
|
| 11.
|
Hemken, P. M.,
Bellin, R. M.,
Sernett, S. W.,
Becker, B.,
Huiatt, T. W.,
and Robson, R. M.
(1997)
J. Biol. Chem.
272,
32489-32499
|
| 12.
|
Bellin, R. M.,
Sernett, S. W.,
Becker, B.,
Ip, W.,
Huiatt, T. W.,
and Robson, R. M.
(1999)
J. Biol. Chem.
274,
29493-29499
|
| 13.
|
Lazarides, E.
(1980)
Nature
283,
249-256
|
| 14.
|
Coulombe, P. A.,
Bousquet, O.,
Ma, L.,
Yamada, S.,
and Wirtz, D.
(2000)
Trends Cell Biol.
10,
420-428
|
| 15.
|
Wiche, G.
(1998)
J. Cell Sci.
111,
2477-2486
|
| 16.
|
Granger, B. L.,
and Lazarides, E.
(1980)
Cell
22,
727-738
|
| 17.
|
Sandoval, I. V.,
Colaco, C. A.,
and Lazarides, E.
(1983)
J. Biol. Chem.
258,
2568-2576
|
| 18.
|
Granger, B. L.,
and Lazarides, E.
(1984)
Mol. Cell. Biol.
4,
1943-1950
|
| 19.
|
Becker, B.,
Bellin, R. M.,
Sernett, S. W.,
Huiatt, T. W.,
and Robson, R. M.
(1995)
Biochem. Biophys. Res. Commun.
213,
796-802
|
| 20.
|
Price, M. G.,
and Lazarides, E.
(1983)
J. Cell Biol.
97,
1860-1874
|
| 21.
|
Bilak, S. R.,
Sernett, S. W.,
Bilak, M. M.,
Bellin, R. M.,
Stromer, M. H.,
Huiatt, T. W.,
and Robson, R. M.
(1998)
Arch. Biochem. Biophys.
355,
63-76
|
| 22.
|
Granger, B. L.,
and Lazarides, E.
(1982)
Cell
30,
263-275
|
| 23.
|
Granger, B. L.,
Repasky, E. A.,
and Lazarides, E.
(1982)
J. Cell Biol.
92,
299-312
|
| 24.
|
Sultana, S.,
Sernett, S. W.,
Bellin, R. M.,
Robson, R. M.,
and Skalli, O.
(2000)
Glia
30,
143-153
|
| 25.
|
Evans, R. R.,
Robson, R. M.,
and Stromer, M. H.
(1984)
J. Biol. Chem.
259,
3916-3924
|
| 26.
|
Johnson, R. P.,
and Craig, S. W.
(1995)
Biochem. Biophys. Res. Commun.
210,
159-164
|
| 27.
|
Carpenter, D. A.,
and Ip, W.
(1996)
J. Cell Sci.
109,
2493-2498
|
| 28.
|
Meng, J. J.,
Khan, S.,
and Ip, W.
(1996)
J. Biol. Chem.
271,
1599-1604
|
| 29.
|
Chevray, P. M.,
and Nathans, D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5789-5793
|
| 30.
|
Meng, J. J.,
Bornslaeger, E. A.,
Green, K. J.,
Steinert, P. M.,
and Ip, W.
(1997)
J. Biol. Chem.
272,
21495-21503
|
| 31.
|
Meng, J. J.,
and Ip, W.
(2001)
Methods Mol. Biol.
161,
255-268
|
| 32.
|
Johnson, R. P.,
and Craig, S. W.
(1994)
J. Biol. Chem.
269,
12611-12619
|
| 33.
|
Weekes, J.,
Barry, S. T.,
and Critchley, D. R.
(1996)
Biochem. J.
314,
827-832
|
| 34.
|
Pardo, J. V.,
Siliciano, J. D.,
and Craig, S. W.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
1008-1012
|
| 35.
|
Craig, S. W.,
and Pardo, J. V.
(1983)
Cell Motil.
3,
449-462
|
| 36.
|
Giniger, E.,
and Ptashne, M.
(1987)
Nature
330,
670-672
|
| 37.
|
Steinert, P. M.,
and Roop, D. R.
(1988)
Annu. Rev. Biochem.
57,
593-625
|
| 38.
|
Baron, M. D.,
Davison, M. D.,
Jones, P.,
and Critchley, D. R.
(1987)
J. Biol. Chem.
262,
17623-17629
|
| 39.
|
Arimura, C.,
Suzuki, T.,
Yanagisawa, M.,
Imamura, M.,
Hamada, Y.,
and Masaki, T.
(1988)
Eur. J. Biochem.
177,
649-655
|
| 40.
|
Gilmore, A. P.,
and Burridge, K.
(1996)
Nature
381,
531-535
|
| 41.
|
Stappenbeck, T. S.,
Bornslaeger, E. A.,
Corcoran, C. M.,
Luu, H. H.,
Virata, M. L.,
and Green, K. J.
(1993)
J. Cell Biol.
123,
691-705
|
| 42.
|
North, A. J.,
Bardsley, W. G.,
Hyam, J.,
Bornslaeger, E. A.,
Cordingley, H. C.,
Trinnaman, B.,
Hatzfeld, M.,
Green, K. J.,
Magee, A. I.,
and Garrod, D. R.
(1999)
J. Cell Sci.
112,
4325-4336
|
| 43.
|
Kowalczyk, A. P.,
Bornslaeger, E. A.,
Norvell, S. M.,
Palka, H. L.,
and Green, K. J.
(1999)
Int. Rev. Cytol.
185,
237-302
|
| 44.
|
Burridge, K.,
and Chrzanowska-Wodnicka, M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
463-518
|
| 45.
|
Belkin, A. M.,
Ornatsky, O. I.,
Glukhova, M. A.,
and Koteliansky, V. E.
(1988)
J. Cell Biol.
107,
545-553
|
| 46.
|
Imanaka-Yoshida, K.,
Danowski, B. A.,
Sanger, J. M.,
and Sanger, J. W.
(1996)
Cell Motil. Cytoskeleton
33,
263-275
|
| 47.
|
Imanaka-Yoshida, K.,
Enomoto-Iwamoto, M.,
Yoshida, T.,
and Sakakura, T.
(1999)
Cell Motil. Cytoskeleton
42,
1-11
|
| 48.
|
Severs, N. J.
(2000)
Bioessays
22,
188-199
|
| 49.
|
Otey, C. A.,
Vasquez, G. B.,
Burridge, K.,
and Erickson, B. W.
(1993)
J. Biol. Chem.
268,
21193-21197
|
| 50.
|
Schmidt, J. M.,
Zhang, J.,
Lee, H. S.,
Stromer, M. H.,
and Robson, R. M.
(1999)
Arch. Biochem. Biophys.
366,
139-150
|
| 51.
|
Critchley, D. R.,
Holt, M. R.,
Barry, S. T.,
Priddle, H.,
Hemmings, L.,
and Norman, J.
(1999)
Biochem. Soc. Symp.
65,
79-99
|
| 52.
|
Small, J. V.,
Furst, D. O.,
and Thornell, L. E.
(1992)
Eur. J. Biochem.
208,
559-572
|
| 53.
|
Danowski, B. A.,
Imanaka-Yoshida, K.,
Sanger, J. M.,
and Sanger, J. W.
(1992)
J. Cell Biol.
118,
1411-1420
|
| 54.
|
Chien, C. T.,
Bartel, P. L.,
Sternglanz, R.,
and Fields, S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9578-9582
|
| 55.
|
Steinert, P. M.,
Chou, Y. H.,
Prahlad, V.,
Parry, D. A.,
Marekov, L. N.,
Wu, K. C.,
Jang, S. I.,
and Goldman, R. D.
(1999)
J. Biol. Chem.
274,
9881-9890
|
| 56.
|
Bellin, R. M.,
Sernett, S. W.,
and Robson, R. M.
(1999)
in
Guidebook to the Cytoskeletal and Motor Proteins
(Kreis, T.
, and Vale, R., eds), 2nd Ed.
, pp. 322-324, Oxford University Press, Oxford, United Kingdom
|
| 57.
|
Shoeman, R. L.,
and Traub, P.
(1993)
Bioessays
15,
605-611
|
| 58.
|
Meng, J. J.,
Khan, S.,
and Ip, W.
(1994)
J. Biol. Chem.
269,
18679-18685
|
| 59.
|
Letai, A.,
and Fuchs, E.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
92-96
|
| 60.
|
Djinovic-Carugo, K.,
Young, P.,
Gautel, M.,
and Saraste, M.
(1999)
Cell
98,
537-546
|
| 61.
|
Bakolitsa, C.,
de Pereda, J. M.,
Bagshaw, C. R.,
Critchley, D. R.,
and Liddington, R. C.
(1999)
Cell
99,
603-613
|
| 62.
|
Steimle, P. A.,
Hoffert, J. D.,
Adey, N. B.,
and Craig, S. W.
(1999)
J. Biol. Chem.
274,
18414-18420
|
| 63.
|
Johnson, R. P.,
and Craig, S. W.
(2000)
J. Biol. Chem.
275,
95-105
|
| 64.
|
Adey, N. B.,
and Kay, B. K.
(1997)
Biochem. J.
324,
523-528
|
| 65.
|
Foisner, R.
(1997)
Bioessays
19,
297-305
|
| 66.
|
Yuan, J.,
Huiatt, T. W.,
Liao, C. X.,
Robson, R. M.,
and Graves, D. J.
(1999)
Arch. Biochem. Biophys.
363,
314-322
|
| 67.
|
Hijikata, T.,
Murakami, T.,
Imamura, M.,
Fujimaki, N.,
and Ishikawa, H.
(1999)
J. Cell Sci.
112,
867-876
|
| 68.
|
Schroder, R.,
Warlo, I.,
Herrmann, H.,
van der Ven, P. F.,
Klasen, C.,
Blumcke, I.,
Mundegar, R. R.,
Furst, D. O.,
Goebel, H. H.,
and Magin, T. M.
(1999)
Eur J. Cell Biol.
78,
288-295
|
| 69.
|
Schroder, R.,
Furst, D. O.,
Klasen, C.,
Reimann, J.,
Herrmann, H.,.,
and van der Ven, P. F.
(2000)
Lab. Invest.
80,
455-464
|
| 70.
|
Steinbock, F. A.,
and Wiche, G.
(1999)
Biol. Chem.
380,
151-158
|
| 71.
|
Svitkina, T. M.,
Verkhovsky, A. B.,
and Borisy, G. G.
(1996)
J. Cell Biol.
135,
991-1007
|
| 72.
|
Reipert, S.,
Steinbock, F.,
Fischer, I.,
Bittner, R. E.,
Zeold, A.,
and Wiche, G.
(1999)
Exp. Cell Res.
252,
479-491
|
| 73.
|
Granger, B. L.,
and Lazarides, E.
(1979)
Cell
18,
1053-1063
|
| 74.
|
Richardson, F. L.,
Stromer, M. H.,
Huiatt, T. W.,
and Robson, R. M.
(1981)
Eur. J. Cell Biol.
26,
91-101
|
| 75.
|
Tokuyasu, K. T.,
Dutton, A. H.,
and Singer, S. J.
(1983)
J. Cell Biol.
96,
1736-1742
|
| 76.
|
Carlsson, L.,
Li, Z. L.,
Paulin, D.,
Price, M. G.,
Breckler, J.,
Robson, R. M.,
Wiche, G.,
and Thornell, L. E.
(2000)
Histochem. Cell Biol.
114,
39-47
|
| 77.
|
Schweitzer, S. C.,
Klymkowsky, M. W.,
Bellin, R. M.,
Robson, R. M.,
Capetanaki, Y.,
and Evans, R. M.
(2001)
J. Cell Sci.
114,
1079-1089
|
| 78.
|
Agbulut, O.,
Li, Z.,
Mouly, V.,
and Butler-Browne, G. S.
(1996)
Biol. Cell
88,
131-135
|
| 79.
|
Li, Z.,
Colucci-Guyon, E.,
Pincon-Raymond, M.,
Mericskay, M.,
Pournin, S.,
Paulin, D.,
and Babinet, C.
(1996)
Dev. Biol.
175,
362-366
|
| 80.
|
Li, Z.,
Mericskay, M.,
Agbulut, O.,
Butler-Browne, G.,
Carlsson, L.,
Thornell, L. E.,
Babinet, C.,
and Paulin, D.
(1997)
J. Cell Biol.
139,
129-144
|
| 81.
|
Milner, D. J.,
Weitzer, G.,
Tran, D.,
Bradley, A.,
and Capetanaki, Y.
(1996)
J. Cell Biol.
134,
1255-1270
|
| 82.
|
Thornell, L.,
Carlsson, L.,
Li, Z.,
Mericskay, M.,
and Paulin, D.
(1997)
J. Mol. Cell. Cardiol.
29,
2107-2124
|
| 83.
|
Capetanaki, Y.,
Milner, D. J.,
and Weitzer, G.
(1997)
Cell Struct. Funct.
22,
103-116
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Konieczny, P. Fuchs, S. Reipert, W. S. Kunz, A. Zeold, I. Fischer, D. Paulin, R. Schroder, and G. Wiche
Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms
J. Cell Biol.,
October 17, 2008;
181(4):
667 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Pan, R. Jing, A. Pitre, B. J. Williams, and O. Skalli
Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton
FASEB J,
September 1, 2008;
22(9):
3196 - 3206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hijikata, A. Nakamura, K. Isokawa, M. Imamura, K. Yuasa, R. Ishikawa, K. Kohama, S. Takeda, and H. Yorifuji
Plectin 1 links intermediate filaments to costameric sarcolemma through {beta}-synemin, {alpha}-dystrobrevin and actin
J. Cell Sci.,
June 15, 2008;
121(12):
2062 - 2074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Stone, A. O'Neill, R. M. Lovering, J. Strong, W. G. Resneck, P. W. Reed, D. M. Toivola, J. A. Ursitti, M. B. Omary, and R. J. Bloch
Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization
J. Cell Sci.,
November 15, 2007;
120(22):
3999 - 4008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Kleeberger, G. S. Bova, M. E. Nielsen, M. Herawi, A.-Y. Chuang, J. I. Epstein, and D. M. Berman
Roles for the Stem Cell Associated Intermediate Filament Nestin in Prostate Cancer Migration and Metastasis
Cancer Res.,
October 1, 2007;
67(19):
9199 - 9206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim and P. A. Coulombe
Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm
Genes & Dev.,
July 1, 2007;
21(13):
1581 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jing, U. Wilhelmsson, W. Goodwill, L. Li, Y. Pan, M. Pekny, and O. Skalli
Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks
J. Cell Sci.,
April 1, 2007;
120(7):
1267 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Rezniczek, P. Konieczny, B. Nikolic, S. Reipert, D. Schneller, C. Abrahamsberg, K. E. Davies, S. J. Winder, and G. Wiche
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with {beta}-dystroglycan
J. Cell Biol.,
March 26, 2007;
176(7):
965 - 977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Uyama, L Zhao, E Van Rossen, Y Hirako, H Reynaert, D H Adams, Z Xue, Z Li, R Robson, M Pekny, et al.
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions
Gut,
September 1, 2006;
55(9):
1276 - 1289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bar, N. Mucke, A. Kostareva, G. Sjoberg, U. Aebi, and H. Herrmann
Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages
PNAS,
October 18, 2005;
102(42):
15099 - 15104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Stone, A. O'Neill, D. Catino, and R. J. Bloch
Specific Interaction of the Actin-binding Domain of Dystrophin with Intermediate Filaments Containing Keratin 19
Mol. Biol. Cell,
September 1, 2005;
16(9):
4280 - 4293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bar, D. Fischer, B. Goudeau, R. A. Kley, C. S. Clemen, P. Vicart, H. Herrmann, M. Vorgerd, and R. Schroder
Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro
Hum. Mol. Genet.,
May 15, 2005;
14(10):
1251 - 1260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Ursitti, P. C. Lee, W. G. Resneck, M. M. McNally, A. L. Bowman, A. O'Neill, M. R. Stone, and R. J. Bloch
Cloning and Characterization of Cytokeratins 8 and 19 in Adult Rat Striated Muscle: INTERACTION WITH THE DYSTROPHIN GLYCOPROTEIN COMPLEX
J. Biol. Chem.,
October 1, 2004;
279(40):
41830 - 41838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schroder, B. Goudeau, M. C. Simon, D. Fischer, T. Eggermann, C. S. Clemen, Z. Li, J. Reimann, Z. Xue, S. Rudnik-Schoneborn, et al.
On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria
Hum. Mol. Genet.,
March 15, 2003;
12(6):
657 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bagnato, V. Barone, E. Giacomello, D. Rossi, and V. Sorrentino
Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles
J. Cell Biol.,
January 21, 2003;
160(2):
245 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Poon, E. V. Howman, S. E. Newey, and K. E. Davies
Association of Syncoilin and Desmin. LINKING INTERMEDIATE FILAMENT PROTEINS TO THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX
J. Biol. Chem.,
January 25, 2002;
277(5):
3433 - 3439.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|